2 drug(s) with this reaction
1,734 total reports
Product Adhesion Issue has been reported as an adverse reaction across 2 drug(s) manufactured by Haleon Us Holdings Llc in the FDA Adverse Event Reporting System (FAERS) database. A combined total of 1,734 adverse event reports mention product adhesion issue in connection with Haleon Us Holdings Llc products.
This page provides a breakdown of which Haleon Us Holdings Llc drugs are most commonly associated with product adhesion issue, along with report counts and links to detailed safety analyses for each medication. Understanding which drugs from a single manufacturer share a common adverse reaction can help patients and healthcare providers identify potential class-wide safety patterns.
The following Haleon Us Holdings Llc drugs have product adhesion issue listed in their FDA adverse event reports, sorted by report count:
In addition to product adhesion issue, the following adverse reactions have been reported across Haleon Us Holdings Llc's drug portfolio:
2 drug(s) manufactured by Haleon Us Holdings Llc have product adhesion issue listed in their FDA adverse event reports: NICOTINE, NICOTINE POLACRILEX.
There are a combined 1,734 reports of product adhesion issue across 2 Haleon Us Holdings Llc drug(s) in the FDA adverse event database.